Cognition in school-aged children with "active" epilepsy: A population-based study

Colin Reilly1, Patricia Atkinson, Krishna B Das

  • 1a Research Department , Young Epilepsy , Lingfield , UK.

Insights

Children with active epilepsy often experience cognitive impairments, particularly in working memory and processing speed. Factors like polytherapy and ADHD predict these difficulties, highlighting the need for targeted interventions.

Area of Science:

  • Child Neurology
  • Developmental Psychology
  • Neuroscience

Background:

  • Population-based data on cognitive profiles in childhood epilepsy is scarce.
  • This study addresses the need for understanding cognitive impairments in children with active epilepsy.

Purpose of the Study:

  • To determine the frequency of global cognitive impairments and specific deficits in working memory and processing speed in children with active epilepsy.
  • To identify factors associated with cognitive difficulties in this population.

Main Methods:

  • A population-based sample of 85 school-aged children (5-15 years) with active epilepsy underwent comprehensive psychological assessments.
  • Cognitive subtest scores were compared using paired-samples t tests, and associated factors were analyzed via linear regression.

Main Results:

  • 40% of children had IQ scores below 70, with significant weaknesses in processing speed (Coding subtest).
  • 58% showed "memory underachievement" on working memory tasks.
  • Polytherapy and ADHD were associated with globally impaired cognition; polytherapy also linked to lower working memory and processing speed scores. Developmental coordination disorder (DCD) was associated with lower processing speed.

Conclusions:

  • Childhood epilepsy is associated with high rates of global and specific cognitive difficulties, especially in working memory and processing speed.
  • Epilepsy-related and behavioral factors predict cognitive impairment, varying by cognitive domain.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.3K
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
830
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
901